A dose response curve of percent inhibition was fit to a sigmoidal doseCresponse model in XLfit. The lack of effect of Trovirdine rilzabrutinib on T cells was assessed in TCR-induced activation (CD3/CD28) and calcium fluxCinduced (thapsigargin) activation assays. FcR signaling